Mutation at codon 130 in hepatitis B virus (HBV) core region increases markedly during acute exacerbation of hepatitis in chronic HBV carriers

Mutations within T-cell or B-cell epitopes are suggested to have some influence on the clinical course of chronic hepatitis B virus (HBV) infection. To investigate the relationship between liver cell injury and heterogeneity of the HBV core gene, we focused on the sequence of codon 130, which is loc...

Full description

Saved in:
Bibliographic Details
Published in:Journal of gastroenterology 2001-02, Vol.36 (2), p.103-110
Main Authors: Okumura, A, Ishikawa, T, Yoshioka, K, Yuasa, R, Fukuzawa, Y, Kakumu, S
Format: Article
Language:English
Subjects:
Adolescent
Adult
Carrier State - blood
Carrier State - virology
Codon
Female
Genes, Viral
Hepatitis B virus - genetics
Hepatitis B, Chronic - blood
Hepatitis B, Chronic - virology
Humans
Male
Middle Aged
Mutation
Polymerase Chain Reaction
Polymorphism, Restriction Fragment Length
Proline
Threonine
Transaminases - blood
Viral Core Proteins
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mutations within T-cell or B-cell epitopes are suggested to have some influence on the clinical course of chronic hepatitis B virus (HBV) infection. To investigate the relationship between liver cell injury and heterogeneity of the HBV core gene, we focused on the sequence of codon 130, which is located on both T- and B-cell epitopes, and serially analyzed the proportion of mutant virus (core130Thr) to wild-type virus (core130Pro) during the exacerbation of chronic hepatitis B. Sera obtained serially from five HBV carriers who had exacerbation of hepatitis, and three asymptomatic HBV carriers (ASCs) with persistently normal serum aminotransferase (ALT) values were studied, using the restriction fragment length polymorphism (RFLP) method. Core130Pro predominated in the sera in the remission state, but core130Thr increased markedly in parallel with ALT elevation and decreased again after the ALT peak, followed by the predominance of core130Pro, in all the five patients. In one patient, the ratio of core130Thr/core130Pro (Thr/Pro) was more than 70% at the ALT peak. On the other hand, in sera from the three ASCs core130Pro always predominated, and no divergence was identified in the ratio of Thr/Pro. Our data suggest that codon 130 is one of the most important immunogenic regions in the HBV core gene and that elevation of Thr/Pro could be the result of immune selection.
ISSN:0944-1174
1435-5922
DOI:10.1007/s005350170138